Eroding Profitability of Domestic Pharmaceutical Firms

Published: 2004-12-10 06:58:00

Updated: 2004-12-10 06:58:00

The domestic pharmaceutical manufacturers are showing an overall growth in sales, but are suffering from margin erosions and lower profitability, reported by the Korea Health Industry Development Institute (KHIDI) from its research on 55 domestic pharmaceutical companies that are listed on KOSDAQ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK